A new Care Quality Commission (CQC)-registered medical cannabis clinic called Medecan has debuted in the UK.
The clinic is co-founded by NHS GP and chief medical officer of Medecan, Dr David Eccleston, chief executive officer David Waller, chief resources officer Laura Eccleston, and is supported by a patient care co-ordinator and operations manager.
The company shares that Medecan provides a fully regulated, transparent and clinically robust pathway for patients living with a range of conditions, including chronic pain, cancer, inflammatory and neurological disorders, gastrointestinal conditions, women’s health concerns, post-traumatic stress disorder, anxiety and sleep disorders.
Dr Eccleston commented, “Like many clinicians, my early experience of cannabis was shaped by only seeing the harms of high tetrahydrocannabinol (THC) recreational use. It was only after seeing the science, regulation and patient outcomes associated with medical cannabis that my perspective completely changed. It’s about carefully balanced, reproducible medicine that can transform quality of life.”